Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE: 002603)
China flag China · Delayed Price · Currency is CNY
17.34
+0.08 (0.46%)
Oct 10, 2024, 3:04 PM CST

Shijiazhuang Yiling Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
27,66738,54350,05432,74630,36514,801
Upgrade
Market Cap Growth
-40.33%-23.00%52.86%7.84%105.15%17.30%
Upgrade
Enterprise Value
27,71238,84448,80632,89028,78713,533
Upgrade
Last Close Price
16.5622.6428.8118.6316.718.09
Upgrade
PE Ratio
99.9527.9720.3723.1622.9122.20
Upgrade
PS Ratio
3.403.743.993.243.462.54
Upgrade
PB Ratio
2.413.374.583.613.401.86
Upgrade
P/FCF Ratio
-46.21-248.0615.29-226.0468.79-38.39
Upgrade
P/OCF Ratio
-98.16247.9314.3561.9419.14214.74
Upgrade
EV/Sales Ratio
3.413.763.893.253.282.32
Upgrade
EV/EBITDA Ratio
30.5318.0514.8217.5816.9914.86
Upgrade
EV/EBIT Ratio
86.7424.0817.1021.6620.1820.79
Upgrade
EV/FCF Ratio
-49.99-250.0014.91-227.0465.22-35.10
Upgrade
Debt / Equity Ratio
0.110.120.080.140.030.01
Upgrade
Debt / EBITDA Ratio
1.410.660.260.650.160.05
Upgrade
Debt / FCF Ratio
-2.32-9.130.27-8.480.61-0.13
Upgrade
Asset Turnover
0.460.620.860.830.850.66
Upgrade
Inventory Turnover
1.801.982.472.272.231.76
Upgrade
Quick Ratio
0.990.840.951.151.494.28
Upgrade
Current Ratio
1.491.471.501.892.446.28
Upgrade
Return on Equity (ROE)
2.31%12.02%23.57%14.91%14.40%7.77%
Upgrade
Return on Assets (ROA)
1.14%6.05%12.20%7.78%8.67%4.62%
Upgrade
Return on Capital (ROIC)
1.55%8.18%16.14%9.74%10.37%5.23%
Upgrade
Earnings Yield
1.00%3.51%4.72%4.10%4.01%4.10%
Upgrade
FCF Yield
-2.00%-0.40%6.54%-0.44%1.45%-2.60%
Upgrade
Dividend Yield
1.73%1.33%1.74%1.61%4.27%1.77%
Upgrade
Payout Ratio
314.20%64.54%11.96%90.79%20.03%19.75%
Upgrade
Buyback Yield / Dilution
0.00%0.01%-0.01%0.00%-0.35%0.79%
Upgrade
Total Shareholder Return
1.73%1.33%1.73%1.61%3.93%2.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.